C11orf82 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8IXT1 |
---|---|
Clone Names | 91230007 |
Gene ID | 220042 |
---|---|
Other Names | DNA damage-induced apoptosis suppressor protein, Nitric oxide-inducible gene protein, DDIAS, C11orf82, NOXIN |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | DDIAS |
---|---|
Synonyms | C11orf82, NOXIN |
Function | May be an anti-apoptotic protein involved in DNA repair or cell survival. |
Cellular Location | Cytoplasm. Nucleus. Note=Accumulates in the nucleus in response to stress. |
Tissue Location | Highly expressed in colorectal and lung cancer tissues. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
NOXIN acts as an anti-apoptotic factor and its absence increases cell death under normal and stress conditions. Can induce cell cycle arrest in the G1 or early S phase and this activity is independent of TP53/p53 (By similarity).
References
Nakaya, N., et al. Mol. Cell. Biol. 27(15):5430-5444(2007)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.